LIVESTOCK NEWS
Beef Processors Uneasy About Zilmax
Tue Jul 15, 2014 06:16 PM CDT

(Dow Jones) -- A sweeping effort by Merck & Co. to revive a livestock drug it pulled from the U.S. market last year is stalling amid resistance from the nation's largest beef processors.

Merck for months has been preparing to conduct a large-scale study this summer to demonstrate the safety of its Zilmax product. The feed additive was widely used to promote weight gain in U.S. cattle before Merck suspended sales in August 2013 because of concerns in the beef industry that the drug made it difficult for some animals to walk.

The pharmaceutical company has said it wants to ...

Quick View
  • Stay on Top of SDS The distinctive yellow patches of sudden death syndrome (SDS) are surfacing in soybean fields acr...
  • Ample Stocks Ahead Drought recovery in many areas has led to higher stocks, brighter production prospects and modera...
  • Precision Ag Potential Pending Precision agriculture proponents insist the industry can revolutionize agriculture, but first mor...
  • Cash Rent Reset - 2 Iowa farmland owners Fred and Lodean Cook may consider flexible cash leases for the first time th...
  • Iowa Land Gets a Bounce Key Midwest land values are stuck in neutral or sliding below 2014 levels, recently released opin...
  • Canadian Dairy Conundrum Coping with Canada's dairy industry import tariffs and supply controls remains one of the stickin...
  • Klinefelter: By the Numbers Deteriorating profit margins flip the fortunes of big renters and conservative owner-operators. I...
  • Training for Sustainability The Hmong American Farmers Association is helping producers who migrated to the United States fol...
  • Ask the Vet What are these crusty scabs on my cattle?
Related News Stories
DTN Closing Livestock Comments
DTN's Livestock Quick Takes
DTN Before The Bell-Livestock
DTN Closing Livestock Comments
DTN Before The Bell-Livestock
The Market's Fine Print
DTN Closing Livestock Comments
DTN Before The Bell-Livestock
DTN Closing Livestock Comments